Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

780 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HER2 expression in cervical cancer as a potential therapeutic target.
Chavez-Blanco A, Perez-Sanchez V, Gonzalez-Fierro A, Vela-Chavez T, Candelaria M, Cetina L, Vidal S, Dueñas-Gonzalez A. Chavez-Blanco A, et al. Among authors: vidal s. BMC Cancer. 2004 Sep 1;4:59. doi: 10.1186/1471-2407-4-59. BMC Cancer. 2004. PMID: 15341668 Free PMC article.
Hydralazine and magnesium valproate as epigenetic treatment for myelodysplastic syndrome. Preliminary results of a phase-II trial.
Candelaria M, Herrera A, Labardini J, González-Fierro A, Trejo-Becerril C, Taja-Chayeb L, Pérez-Cárdenas E, de la Cruz-Hernández E, Arias-Bofill D, Vidal S, Cervera E, Dueñas-Gonzalez A. Candelaria M, et al. Among authors: vidal s. Ann Hematol. 2011 Apr;90(4):379-87. doi: 10.1007/s00277-010-1090-2. Epub 2010 Oct 5. Ann Hematol. 2011. PMID: 20922525 Clinical Trial.
A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results.
Coronel J, Cetina L, Pacheco I, Trejo-Becerril C, González-Fierro A, de la Cruz-Hernandez E, Perez-Cardenas E, Taja-Chayeb L, Arias-Bofill D, Candelaria M, Vidal S, Dueñas-González A. Coronel J, et al. Among authors: vidal s. Med Oncol. 2011 Dec;28 Suppl 1:S540-6. doi: 10.1007/s12032-010-9700-3. Epub 2010 Oct 8. Med Oncol. 2011. PMID: 20931299 Clinical Trial.
Transcriptional changes induced by epigenetic therapy with hydralazine and magnesium valproate in cervical carcinoma.
De la Cruz-Hernández E, Perez-Plasencia C, Pérez-Cardenas E, Gonzalez-Fierro A, Trejo-Becerril C, Chávez-Blanco A, Taja-Chayeb L, Vidal S, Gutiérrez O, Dominguez GI, Trujillo JE, Duenas-González A. De la Cruz-Hernández E, et al. Among authors: vidal s. Oncol Rep. 2011 Feb;25(2):399-407. doi: 10.3892/or.2010.1086. Epub 2010 Dec 8. Oncol Rep. 2011. PMID: 21152880
Pharmacokinetics of hydralazine, an antihypertensive and DNA-demethylating agent, using controlled-release formulations designed for use in dosing schedules based on the acetylator phenotype.
Gonzalez-Fierro A, Vasquez-Bahena D, Taja-Chayeb L, Vidal S, Trejo-Becerril C, Pérez-Cardenas E, de la Cruz-Hernández E, Chávez-Blanco A, Gutiérrez O, Rodriguez D, Fernandez Z, Duenas-González A. Gonzalez-Fierro A, et al. Among authors: vidal s. Int J Clin Pharmacol Ther. 2011 Aug;49(8):519-24. doi: 10.5414/cp201526. Int J Clin Pharmacol Ther. 2011. PMID: 21781652 Clinical Trial.
Alteration of the serum microbiome composition in cirrhotic patients with ascites.
Santiago A, Pozuelo M, Poca M, Gely C, Nieto JC, Torras X, Román E, Campos D, Sarrabayrouse G, Vidal S, Alvarado-Tapias E, Guarner F, Soriano G, Manichanh C, Guarner C. Santiago A, et al. Among authors: vidal s. Sci Rep. 2016 Apr 26;6:25001. doi: 10.1038/srep25001. Sci Rep. 2016. PMID: 27112233 Free PMC article.
IL-6, IL-10 and TNFα do not improve early detection of post-endoscopic retrograde cholangiopancreatography acute pancreatitis: a prospective cohort study.
Concepción-Martín M, Gómez-Oliva C, Juanes A, Mora J, Vidal S, Díez X, Torras X, Sainz S, Villanueva C, Farré A, Guarner-Argente C, Guarner C. Concepción-Martín M, et al. Among authors: vidal s. Sci Rep. 2016 Sep 19;6:33492. doi: 10.1038/srep33492. Sci Rep. 2016. PMID: 27642079 Free PMC article.
Functional consequences of CD36 downregulation by TLR signals.
Zamora C, Cantó E, Nieto JC, Angels Ortiz M, Juarez C, Vidal S. Zamora C, et al. Among authors: vidal s. Cytokine. 2012 Oct;60(1):257-65. doi: 10.1016/j.cyto.2012.06.020. Epub 2012 Jul 12. Cytokine. 2012. PMID: 22795952
780 results